COFEPRIS points out that any product marketed as a COVID-19 vaccine, regardless of its packaging, brand or location, constitutes fraud and is a health risk because it is of dubious origin.
COFEPRIS has not issued a license to any individual for the sale or import of vaccines
At the moment, this commission has not issued a license to any individual for the sale or import of these vaccines. Therefore, people may consider any offer of this type to be illegal and a health risk.
The Federal Commission for the Protection against Sanitary Risks (Cofepris), remember that the application of the preventive vaccine against COVID-19 is free. And that each batch must be inspected and analyzed by regulatory authorities to verify its effectiveness and safety.
Receiving a biological that does not have information about its origin, manufacture, storage, or expiration. It does not offer any certainty about its effectiveness in preventing the spread of the SARS-CoV-2 virus (COVID-19).
An apocryphal or irregular product may contain dangerous substances or be contaminated, making it a high risk to health by injecting it into the body. All vaccines within the National Vaccination Plan meet quality and safety requirements and are within the specifications for their application.
WARNING
If you know of any establishment, hospital, doctor’s office, pharmacy or any other point of sale that offers any product passing it off as a vaccine against COVID-19. You are invited to make a health complaint through the page gob.mx/Cofepris.
About the reports of a clandestine vaccination establishment for children and adolescents located in the State of Mexico. Cofepris indicates that verification and health surveillance actions are underway. Collaboration will be made with law enforcement institutions for actions that constitute criminal conduct.
An active pharmacovigilance group dedicated to this case was also established. Therefore, people are urged, particularly those responsible, fathers and mothers of minors who have applied any alleged vaccine outside authorized units. To report any adverse reaction or discomfort through the mail [email protected]; You are requested to identify your notification with the word “clandestine” in the description.
Cofepris maintains surveillance actions to prevent products, companies or establishments from failing to comply with current health legislation and not representing a risk to the health of the population.
IMSS: this is how we can avoid COVID complications in people with chronic diseases
They create a tool to predict who will experience prolonged COVID
The 14 symptoms of Omicron ranked from highest to lowest prevalence